Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
WeGene logo — 解读基因的秘密, 遇见未来的自己

WeGene

解读基因的秘密, 遇见未来的自己

Founded 2014 China China 12 employees Series B Total: $43.00M Biotechnology, Data Analytics +1

General Information

Company Name WeGene
Founded Year 2014
Location China China
Employees 12
Industries Biotechnology, Data Analytics, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with WeGene. To contact WeGene, visit wegene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does WeGene compare?

A PDF of WeGene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting WeGene soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About WeGene

WeGene is a pioneering Chinese consumer-facing genetic testing company, established in 2014. With the slogan "解读基因的秘密, 遇见未来的自己," the company has garnered significant attention in the biotechnology and healthcare industries. WeGene has secured notable CNY20.00M Series B investment on 29 January 2018 from a consortium of investors including Puhua Capital, Zhuojia Huizhi Chuangtou, Fengji Touzi, Bioclub, Lanse Caihong Keji, Huada Yixue, and Hangzhou Fuzhuo Investment Management. Being the genetic testing company with the highest user base in China, WeGene offers a range of products including ancestry analysis, personalized exercise and weight management recommendations, nutritional genomics, and genomic medicine. The company has also engaged in research collaborations with prominent domestic and international institutions such as Shanghai Jiao Tong University, Hong Kong University of Science and Technology, Renmin University of China, Xiamen University, and the Chinese Academy of Sciences. WeGene's focus on using scientific methods to help consumers understand and utilize their genetic data reflects a commitment to driving meaningful utilization of genetic information. By leveraging the understanding and collaborative research on genetic data, the company aims to facilitate disease research and contribute to the development of new drugs. With a prevailing belief in data-driven decision-making and scientific methodologies, WeGene is dedicated to advancing the utilization of genetic data for the betterment of human health.

Business keywords: Genetic Testing, Consumer Genetics, Personalized Medicine, Research Collaboration, Genomics, Health Data Analysis, Nutrigenomics, Exercise Genetics, Investment, Data-driven Health Solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY20.00M 7
Puhua Capital Zhuojia Huizhi Chuangtou
Puhua Capital, Zhuojia Huizhi Chuangtou +5
29 Jan 2018
Series A CNY20.00M 2
K2 Jijin, Fengji Touzi
01 Sep 2015
Angel Round CNY3.00M -
25 Sep 2014

WeGene Alternatives & Competitors

View All Alternatives
WeGene vs
Xcode Life Sciences
Xcode Life Sciences

Empowering lives through personalized genomic insights for optimal health and well-being.

Seed
2-10 employees
Biotechnology, Health Care
WeGene vs
Sano Genetics
Sano Genetics United Kingdom

Accelerating the world's transition to precision medicine.

50 employees
Biopharma, Biotechnology
WeGene vs
NalaGenetics
NalaGenetics Singapore

Unlock your health secrets through the power of DNA

Non Equity Assistance
73 employees
Biotechnology, Health Care
View all alternatives

FAQ About WeGene

解读基因的秘密, 遇见未来的自己
WeGene was founded in 2014.
WeGene is headquartered in China.
WeGene operates in Biotechnology, Data Analytics and Health Care. Its work centres on Genetic Testing, Consumer Genetics, Personalized Medicine and Research Collaboration.
WeGene has approximately 12 employees.
WeGene has completed 3 funding rounds, raising a total of $43.00M. The latest funding stage is Series B.
Top alternatives and competitors to WeGene include Xcode Life Sciences, Sano Genetics, NalaGenetics, Lobo Genetics, Genoplan . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
WeGene and Xcode Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for WeGene, https://www.bouncewatch.com/company/wegene, updated 16 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout